Reconciling ACEA and MCDA: is there a way forward for measuring cost-effectiveness in the U.S. healthcare setting?

Zamora, Bernarda; Garrison, Louis P; Unuigbe, Aig; Towse, Adrian

Zamora, Bernarda; Garrison, Louis P; Unuigbe, Aig; Towse, Adrian.

Afiliação

Zamora B; Office of Health Economics, Southside, 105 Victoria Street, London, SW1E 6QT, UK.
Garrison LP; The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute, University of Washington, Magnuson Health Sciences Building, H Wing, H-375, Box 357630, 98195, Seattle, WA, USA. lgarrisn@uw.edu.
Unuigbe A; The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute, University of Washington, Magnuson Health Sciences Building, H Wing, H-375, Box 357630, 98195, Seattle, WA, USA.
Towse A; Office of Health Economics, Southside, 105 Victoria Street, London, SW1E 6QT, UK.

Cost Eff Resour Alloc ; 19(1): 13, 2021 Mar 01.

Article em En | MEDLINE | ID: mdl-33648523

Palavras-chave

Augmented Cost-Effectiveness Analysis; Multi-criteria Decision Analysis; QALY; Value trade-off

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Evaluation_studies / Health_economic_evaluation / Prognostic_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google